TW438603B - Microemulsion preparation containing peptide pharmaceuticals - Google Patents

Microemulsion preparation containing peptide pharmaceuticals Download PDF

Info

Publication number
TW438603B
TW438603B TW083103462A TW83103462A TW438603B TW 438603 B TW438603 B TW 438603B TW 083103462 A TW083103462 A TW 083103462A TW 83103462 A TW83103462 A TW 83103462A TW 438603 B TW438603 B TW 438603B
Authority
TW
Taiwan
Prior art keywords
microemulsion
surfactant
oil
water
patent application
Prior art date
Application number
TW083103462A
Other languages
English (en)
Chinese (zh)
Inventor
Masao Takahashi
Hiroshi Matsushita
Original Assignee
Advanced Skin Res Kenkyusho Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Skin Res Kenkyusho Kk filed Critical Advanced Skin Res Kenkyusho Kk
Application granted granted Critical
Publication of TW438603B publication Critical patent/TW438603B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW083103462A 1993-04-19 1994-04-19 Microemulsion preparation containing peptide pharmaceuticals TW438603B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9143893 1993-04-19

Publications (1)

Publication Number Publication Date
TW438603B true TW438603B (en) 2001-06-07

Family

ID=14026380

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083103462A TW438603B (en) 1993-04-19 1994-04-19 Microemulsion preparation containing peptide pharmaceuticals

Country Status (9)

Country Link
US (1) US5948825A (fr)
EP (1) EP0753311B1 (fr)
AT (1) ATE223231T1 (fr)
AU (1) AU686149B2 (fr)
CA (1) CA2160681A1 (fr)
DE (1) DE69431310T2 (fr)
ES (1) ES2182841T3 (fr)
TW (1) TW438603B (fr)
WO (1) WO1994023749A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE10164531A1 (de) * 2001-12-31 2003-07-17 Pharmatech Gmbh Zubereitung zur Oberflächenanästhesie der Haut
DE10226990A1 (de) * 2002-06-18 2004-03-18 Sanguibiotech Ag Topisch applizierbare Mikro-Emulsionen mit binärer Phasen- und Wirkstoffdifferenzierbarkeit, deren Herstellung und deren Verwendung, insbesondere zur Versorgung der Haut mit bioverfügbarem Sauerstoff
US20050075416A1 (en) * 2003-02-21 2005-04-07 Seiko Epson Corporation Process for preparing microencapsulated pigment, microencapsulated pigment, aqueous dispersion, and ink for ink jet recording
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
WO2005027807A1 (fr) 2003-09-19 2005-03-31 Drugtech Corporation Systeme pharmaceutique d'administration
PE20050596A1 (es) * 2003-12-19 2005-10-18 Novartis Ag Microemulsion que comprende un inhibidor renina
US7357957B2 (en) * 2004-05-07 2008-04-15 Fractec Research & Development Inc. Spreadable food product
DE102004049574A1 (de) 2004-10-12 2006-04-20 Doris Dr. Barnikol-Keuten Arzneimittel und System zur perkutanen Arzneistoffverabreichung
JP2006232755A (ja) * 2005-02-25 2006-09-07 Dai Ichi Kogyo Seiyaku Co Ltd 油中水型マイクロエマルション
AU2006244260A1 (en) * 2005-05-09 2006-11-16 Drugtech Corporation Modified-release pharmaceutical compositions
US9743680B2 (en) * 2005-10-14 2017-08-29 Wild Flavors, Inc. Microemulsions for use in food and beverage products
US20070154516A1 (en) * 2006-01-05 2007-07-05 Drugtech Corporation Drug delivery system
AU2006332518A1 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Composition and method of use thereof
AU2007353340A1 (en) 2006-12-01 2008-11-20 Anterios, Inc. Peptide nanoparticles and uses therefor
FR2916966B1 (fr) * 2007-06-11 2011-01-14 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
EP2515865B1 (fr) 2009-12-22 2016-12-14 Leo Pharma A/S Composition cutanée comprenant un analogue de la vitamine d et un mélange de solvant et de tensioactifs
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9168309B2 (en) 2010-12-01 2015-10-27 Omnis Biotechnology Inc. Thixotropic compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2013182688A1 (fr) 2012-06-08 2013-12-12 Leo Laboratories Limited Composition de gel topique comprenant un dérivé ingénol et un mélange de solvants
WO2016033556A1 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Esters de (17-β)-hydroxy-4-androstène-3-one biodisponibles à l'état solide
WO2016033549A2 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation
CN106604722A (zh) * 2014-12-19 2017-04-26 积水化学工业株式会社 制剂
WO2018098501A1 (fr) 2016-11-28 2018-05-31 Lipocine Inc. Traitement oral à base d'undécanoate de testostérone

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731384A (en) * 1983-07-01 1988-03-15 Troponwerke Gmbh & Co, Kg Etofenamate formulation
JPS6061535A (ja) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト 製薬学的組成物
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
JPS60199833A (ja) * 1984-03-26 1985-10-09 Meiji Milk Prod Co Ltd 医薬品、化粧品等用ｗ／ｏ／ｗ型複合エマルジヨンの製造法
JPS6111137A (ja) * 1984-06-26 1986-01-18 Shiseido Co Ltd 油中水型乳化組成物
CA1301642C (fr) * 1987-03-30 1992-05-26 Howard Bernard Dawson Formulations chimiques
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
JPH078806B2 (ja) * 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
DE69229779T2 (de) * 1991-04-19 1999-12-23 Lds Technologies Inc Konvertierbare mikroemulsionsverbindungen
CA2114323A1 (fr) * 1991-07-26 1993-02-18 Panayiotis Pericleous Constantinides Microemulsions eau dans huile
ZA925581B (en) * 1991-07-26 1993-05-14 Smithkline Beecham Corp Pharmaceutical microemulsions.
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
US5496811A (en) * 1992-08-28 1996-03-05 Pharmos Corp. Submicron emulsions as ocular drug delivery vehicles
WO1994008610A1 (fr) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Compositions pour emulsions pharmaceutiques
WO1994008605A1 (fr) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Microemulsions therapeutiques
EP0671929A4 (fr) * 1992-10-16 1996-09-25 Smithkline Beecham Corp Compositions.
WO1994019000A1 (fr) * 1993-02-17 1994-09-01 Smithkline Beecham Corporation Microemulsions contenant des compositions pharmaceutiques
EP0684833A4 (fr) * 1993-02-17 1996-09-11 Smithkline Beecham Corp Micro-emulsions comprenant des peptides therapeutiques.
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles

Also Published As

Publication number Publication date
AU686149B2 (en) 1998-02-05
EP0753311A4 (fr) 1997-05-21
DE69431310T2 (de) 2003-05-22
US5948825A (en) 1999-09-07
DE69431310D1 (de) 2002-10-10
ATE223231T1 (de) 2002-09-15
AU6513494A (en) 1994-11-08
EP0753311A1 (fr) 1997-01-15
EP0753311B1 (fr) 2002-09-04
WO1994023749A1 (fr) 1994-10-27
ES2182841T3 (es) 2003-03-16
CA2160681A1 (fr) 1994-10-27

Similar Documents

Publication Publication Date Title
TW438603B (en) Microemulsion preparation containing peptide pharmaceuticals
CN100558407C (zh) 制备含有胆汁酸的澄清水溶液剂型
CN1191060C (zh) 输送前列腺素e1的表皮给药组合物
US5158761A (en) Spray gel base and spray gel preparation using thereof
US5215739A (en) Spray gel base and spray gel preparation using thereof
US5869090A (en) Transdermal delivery of dehydroepiandrosterone
US8333989B2 (en) Hydrophilic vehicle-based dual controlled release matrix system
US8840919B2 (en) Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
AU2019203188A1 (en) Transdermal compositions of ibuprofen and methods of use thereof
ITMI972106A1 (it) Formulazione per un dispositivo transdermico
CN101616660A (zh) 高剂量膜组合物及其制备方法
BR112014031837B1 (pt) Formulações farmacêuticas líquidas compreendendo progesterona e usos destas
CN104797252B (zh) 减轻噪音厌恶的兽医方法
CN100341577C (zh) 经皮吸收制剂
PT87029B (pt) Processo para a preparacao de um dispositivo auto-adesivo para administracao de um principio activo por via percutanea
CA1314484C (fr) Combination synergetique d'azelastine et de theophylline ou d'azelastine et de substances imitant ces composes
JPH0840880A (ja) 軟ゼラチンカプセル剤中のケトプロフエン溶液に基づく医薬製剤およびその調製法
NZ201415A (en) Anhydrous gel medicament formulations containing water-soluble polymer
JP2540294B2 (ja) 経皮吸収製剤
CN1469707A (zh) 改进的疏水性药物的固体药物剂量制剂
EA007351B1 (ru) Фармацевтическая композиция для чрескожной доставки физиологически активных агентов
TW201223528A (en) Transdermal absorption preparation
JPH072689A (ja) 難吸収性物質を含有するマイクロエマルション製剤
JP2932086B2 (ja) 新規なピコスルファートナトリウム液充填硬カプセル剤
ES2663358T3 (es) Composiciones de dispersión farmacéuticas orales

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees